BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  European Patent Office Maintains FibroGen Patent Relating To Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase Inhibitor Technology

  June 5, 2017

   · 

  5 min read
• Drug Development

  Janssen-Cilag International NV Release: Abiraterone Acetate Provided Significant Clinical Benefit In Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival And Radiographic Progression-Free Survival

  June 5, 2017

   · 

  14 min read
• Pharm Country

  Incyte Analyst And Investor Event To Highlight Clinical Data Presentations From ASCO 2017

  June 5, 2017

   · 

  1 min read
• Drug Development

  Calithera Biosciences Release: CB-1158 (INCB01158) Phase I Solid Tumor Data Presented At The ASCO Annual Meeting

  June 5, 2017

   · 

  5 min read
• Pharm Country

  Nabriva Announces Webcast Of Analyst & Investor Day On June 19, 2017

  June 5, 2017

   · 

  4 min read
• Drug Development

  Updated Data From KEYNOTE-024 Show Continued Overall Survival Benefit Of Merck & Co.’s KEYTRUDA (Pembrolizumab) Compared To Chemotherapy In The First-Line Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) With High Levels Of PD-L1

  June 5, 2017

   · 

  21 min read
• Business

  Oxford Immunotec Names Karen Koski Head Of Strategy And Investor Relations

  June 5, 2017

   · 

  2 min read
• Business

  Novartis AG Announces Ground-Breaking Collaboration With IBM Watson Health On Outcomes-Based Care In Advanced Breast Cancer

  June 5, 2017

   · 

  7 min read
• BioMidwest

  GRAIL Announces Data From Early Research Analyzing Its High-Intensity Sequencing Approach

  June 5, 2017

   · 

  6 min read
• Drug Development

  New Microbiology Data Reinforce Activity Of Paratek Pharma’s Omadacycline Against Pathogens Of Importance In Respiratory, Skin And Urinary Tract Infections

  June 5, 2017

   · 

  7 min read